sunmark dry eye relief- glycerin, hypromellose, polyethylene glycol 400 solution/ drops
strategic sourcing services llc - hypromelloses (unii: 3nxw29v3wo) (hypromellose, unspecified - unii:3nxw29v3wo), glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox), polyethylene glycol 400 (unii: b697894sgq) (polyethylene glycol 400 - unii:b697894sgq) - hypromelloses 0.2 g in 100 ml - purpose glycerin.....lubricant hypromellose.....lubricant polyethylene glycol 400.....lubricant uses - for the temporary relief of burning and irritation due to dryness of the eye - for protection against further irritation
zolpidem tartrate tablet
lake erie medical dba quality care products llc - zolpidem tartrate (unii: wy6w63843k) (zolpidem - unii:7k383oqi23) - zolpidem tartrate tablets, usp are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. zolpidem tartrate tablets, usp have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see ]. clinical studies (14) the clinical trials performed in support of efficacy were 4-5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. zolpidem tartrate tablets are contraindicated in patients with known hypersensitivity to zolpidem. observed reactions include anaphylaxis and angioedema . [see warnings and precautions (5.3)] pregnancy category c there are no adequate and well-controlled studies of zolpidem tartrate tablets in pregnant women. studies in children to assess the effects of prenatal exposure to zolpidem have not been conducted; however, cases of severe neonatal respirator
quality choice lubricant tears eye- glycerin, hypromellose, polyethylene glycol 400 solution/ drops
chain drug marketing association inc - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox), hypromelloses (unii: 3nxw29v3wo) (hypromelloses - unii:3nxw29v3wo), polyethylene glycol 400 (unii: b697894sgq) (polyethylene glycol 400 - unii:b697894sgq) - uses - for the temporary relief of burning and irritation due to dryness of the eye - for protection against further irritation do not use: - if this solution changes color or becomes cloudy or if you are sensitive to any ingredient in this product stop use and ask a doctor if - you feel eye pain - changes in vision occur - redness or irritation of the eye lasts - condition worsens or lasts more than 72 hours directions - instill 1 or 2 drops in the affected eye(s) as needed. - children under 6 years of age: ask a doctor
cry for you lubricant eye drops- glycerin, hypromellose, polyethylene glycol 400 liquid
delsam pharma llc - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox), hypromellose, unspecified (unii: 3nxw29v3wo) (hypromellose, unspecified - unii:3nxw29v3wo), polyethylene glycol 400 (unii: b697894sgq) (polyethylene glycol 400 - unii:b697894sgq) - lubricant • for the temporary relief of burning, irritation and discomfort due to dryness of the eye or exposure to wind or sun • for protection against further irritation
i-drops lubricant eye drops- glycerin, hypromellose, polyethylene glycol 400 solution/ drops
global pharma healthcare private limited - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox), hypromellose, unspecified (unii: 3nxw29v3wo) (hypromellose, unspecified - unii:3nxw29v3wo), polyethylene glycol 400 (unii: b697894sgq) (polyethylene glycol 400 - unii:b697894sgq) - lubricant • for use as a protectant against further irritation or to relieve dryness of the eye. • for the temporary relief of discomfort due to minor irritations of the eye, or to exposure to wind or sun.
octiq lubricant eye drops- dextran 70 hypromellose solution/ drops
innovus pharmaceuticals, inc. - dextran 70 (unii: 7sa290yk68) (dextran 70 - unii:7sa290yk68), hypromellose 2910 (4000 mpa.s) (unii: rn3152op35) (hypromellose 2910 (4000 mpa.s) - unii:rn3152op35) - lubricant lubricant - for the temporary relief of burning and irritation due to dryness of the eye - for the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun - as a protectant against future irritation - if solution changes color or becomes cloudy - if you are sensitive to any ingredient in this product - you feel eye pain - changes in vision occur redness or irritation of the eye gets worse or lasts more than 72 hours
activize comfort drops
amo australia pty limited (nz) - hypromellose 0.15%{relative}; trometamol 1.2%{relative} (mis-spelled as trometamine in dossier); tyloxapol 0.025%{relative} - contact lens solution - active: hypromellose 0.15%{relative} trometamol 1.2%{relative} (mis-spelled as trometamine in dossier) tyloxapol 0.025%{relative} excipient: hydrochloric acid polihexanide purified water sodium chloride sodium edetate
activize rgp solution
amo australia pty limited (nz) - hypromellose 0.15%{relative}; trometamol 1.2%{relative}; tyloxapol 0.025%{relative} - contact lens solution - active: hypromellose 0.15%{relative} trometamol 1.2%{relative} tyloxapol 0.025%{relative} excipient: disodium edetate hydrochloric acid polihexanide purified water sodium chloride
complete
amo australia pty limited (nz) - hypromellose 0.15%{relative}; polihexanide 0.0001%{relative}; trometamol 1.2%{relative}; tyloxapol 0.025%{relative}; - contact lens solution - active: hypromellose 0.15%{relative} polihexanide 0.0001%{relative} trometamol 1.2%{relative} tyloxapol 0.025%{relative} excipient: hydrochloric acid purified water sodium chloride sodium edetate
lonsurf 15/6.14 trifluridine 15 mg/ tipiracil hydrochloride 7.065 mg (equivalent to tipiracil 6.14 mg) film-coated tablet blister pack
servier laboratories (aust) pty ltd - tipiracil hydrochloride, quantity: 7.065 mg; trifluridine, quantity: 15 mg - tablet, film coated - excipient ingredients: carnauba wax; pregelatinised maize starch; lactose monohydrate; iron oxide yellow; titanium dioxide; macrogol 8000; indigo carmine aluminium lake; hypromellose; stearic acid; iron oxide red; shellac; purified talc; magnesium stearate - colorectal cancer lonsurf is indicated for the treatment of adult patients with metastatic colorectal cancer (mcrc) who have been previously treated with, or are not considered candidates for fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti-egfr agents.,gastric cancer lonsurf is indicated for the treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, her2/neu-targeted therapy.